During the past decade, Winston-Salem Health Care conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 9 clinical trials were completed, i.e. on average, 112.5% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Winston-Salem Health Care" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 5 trials, followed by "SWOG Cancer Research Network" with 4 trials sponsored, "National Cancer Institute (NCI)" with 3 trials sponsored, "Gynecologic Oncology Group" with 2 trials sponsored and "GOG Foundation" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Winston-Salem Health Care" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Winston-Salem Health Care" are "Breast Cancer" (2 trials), "Breast Carcinoma" (2 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (2 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (2 trials) and "Fallopian Tube Mucinous Adenocarcinoma" (2 trials). Many other conditions were trialed in "Winston-Salem Health Care" in a lesser frequency.

Most popular intervention types in "Winston-Salem Health Care" are "Drug" (13 trials), "Other" (12 trials), "Biological" (3 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (5 trials), "Quality-of-Life Assessment" (5 trials), "Paclitaxel" (3 trials), "Questionnaire Administration" (3 trials) and "Trastuzumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Winston-Salem Health Care" are 8 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Winston-Salem Health Care". undefined are not yet recruiting, undefined are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Winston-Salem Health Care, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Winston-Salem Health Care, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Winston-Salem Health Care has several departments that took part in Clinical trials: "Novant Health Heart and Vascular Institute" - 35 trials, "Novant Health Breast Surgery - Greensboro" - 7 trials, "Novant Health Pulmonary and Critical Care" - 2 trials, "Novant Health Charlotte Orthopedic Hospital" - 2 trials